News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Paolo Tarantino: Taxanes vs Eribulin for First-Line Metastatic HER2+ Breast Cancer
Paolo Tarantino and Tess O'Meara
Jan 26, 2025, 08:08

Paolo Tarantino: Taxanes vs Eribulin for First-Line Metastatic HER2+ Breast Cancer

Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, posted on X about recent paper by him and Tess O’Meara, Hematology/Oncology Fellow at Dana-Farber Cancer Institute, published in Journal of Clinical Oncology:

“1st line treatment for HER2+ mBC, unchanged for >10 years, is finally evolving. EMERALD introduced 1st line eribulin. PATINA introduced palbo. DB09 may soon introduce T-DXd.

In this editorial, Tess O’Meara and I review this evolution and provide suggestions for Rx tailoring.”

“Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study”

Authors: Paolo Tarantino and Tess O’Meara

Paolo Tarantino: Taxanes vs Eribulin for First-Line Metastatic HER2+ Breast Cancer

More posts featuring Paolo Tarantino.

cancer DB09 EMERALD eribulin HER2+ breast cancer OncoDaily Oncology Paolo Tarantino PATINA taxanes Tess O'Meara
Special Coverage
Blog
Feb 25, 2025, 05:11
MD Anderson receives nearly $23 million in CPRIT funding for cancer research, faculty recruitment
Insight
Feb 24, 2025, 23:46
Cancer death rates almost 60% higher in UK’s most deprived areas - Cancer Research UK
Blog
Feb 24, 2025, 23:27
Xiuning Le: Honored to serve as a co-chair for IASLC TTLC 2026 and 2027
Blog
Feb 24, 2025, 21:24
ICCD 2025 Event Highlights: Speakers’ Quote Series with Ruth Ladenstein - SIOP Europe
Blog
Feb 24, 2025, 15:25
Bibhudatta Mishra: A paradigm shift in oncology
Blog
Feb 24, 2025, 14:55
Esra Bilir: Women Empowerment at ESGO2025
Blog
Feb 24, 2025, 14:51
Celebrating the Black Volunteer Caucus - ACS CAN
Blog
Feb 24, 2025, 14:45
How can radiotherapy become more environmentally friendly? - ESMO
Blog
Feb 24, 2025, 14:22
Vincent Ling: Where does the money go?
Science
Feb 24, 2025, 14:08
JeeSuk Chang: The 2nd analysis of SABR-5
Stories
Feb 24, 2025, 14:00
Remembering Giovanni Scambia: A Legacy in Gynecological Oncology
Insight
Feb 24, 2025, 13:59
Women in Thoracic Surgery Board of Directors